Table 2. Correlation of E2Fs’ genes expression with OS in GC patients with HER2 expression status.
E2Fs | HER2 status | Cases | Low | High | HR (95% CI) | P-value |
---|---|---|---|---|---|---|
E2F1 | Negative | 532 | 292 | 240 | 1.98 (1.58−2.48) | 1.7e−09* |
Positive | 344 | 131 | 213 | 1.93 (1.46−2.55) | 2.7e−06* | |
E2F2 | Negative | 429 | 222 | 207 | 0.6 (0.46−0.79) | 0.00018* |
Positive | 202 | 115 | 87 | 0.6 (0.4−0.88) | 0.0083* | |
E2F3 | Negative | 532 | 361 | 171 | 1.64 (1.3−2.07) | 2.1e−05* |
Positive | 344 | 185 | 159 | 1.76 (1.36−2.29) | 1.6e−05* | |
E2F4 | Negative | 532 | 292 | 240 | 1.84 (1.47−2.3) | 8.1e−08* |
Positive | 344 | 120 | 224 | 2.01 (1.49−2.7) | 2.5e−06* | |
E2F5 | Negative | 532 | 192 | 340 | 0.58 (0.46−0.72) | 1.5e−06* |
Positive | 344 | 126 | 218 | 0.71 (0.55−0.93) | 0.011* | |
E2F6 | Negative | 532 | 201 | 331 | 0.69 (0.55−0.86) | 0.0012* |
Positive | 344 | 156 | 188 | 0.89 (0.68−1.15) | 0.36 | |
E2F7 | Negative | 429 | 154 | 275 | 0.54 (0.41−0.7) | 3.7e−06* |
Positive | 202 | 142 | 60 | 0.65 (0.43−1.01) | 0.051 |
P<0.05.